Liezl Gambe

Capricorn Metals (ASX:CMM) has entered into a binding agreement to acquire the Yalgoo Project from Tempest Minerals (ASX:TEM).

Cryptocurrency mining has emerged as one of several factors underpinning the recent strength of the Russian ruble, according to comments from the country’s central bank leadership.

Dominion Energy (NYSE:D) issued a statement today in response to the U.S. Department of Interior’s Director’s Order, which calls for a 90-day suspension of work on the Coastal Virginia Offshore Wind (CVOW) project.

Zeekr Group (NYSE:ZK) has announced the completion of its merger with Keystone Mergersub, an indirect wholly-owned subsidiary of Geely, effective December 22, 2025.

NeuroSense Therapeutics (NASDAQ:NRSN) reported on Monday the successful completion of a safety analysis for its Phase 2 NST-AD-001 study, a critical step in the company's efforts to repurpose its lead ALS candidate, PrimeC, for the treatment of Alzheimer’s disease.

Stanley Black & Decker (NYSE:SWK) has reached an agreement to sell its Consolidated Aerospace Manufacturing (CAM) business to Howmet Aerospace for $1.8 billion in cash.

The sale is part of Stanley Black & Decker’s strategic efforts to streamline its operations and reduce debt.

Helix Energy Solutions Group (NYSE:HLX) has secured a significant multi-year contract with a major operator for riserless plug and abandonment (P&A) operations on up to 34 subsea wells in the UK North Sea.

The GEO Group (NYSE:GEO), a leading provider of government-contracted services, announced on Monday that its wholly-owned subsidiary, BI Incorporated, has been awarded a significant new contract by U.S. Immigration and Customs Enforcement (ICE).

Honeywell International (NASDAQ:HON) issued a comprehensive update to its financial projections on Monday, recalibrating its 2025 guidance to account for the strategic spin-off of its Advanced Materials business.

Alvotech (NASDAQ:ALVO) achieved a significant milestone in the competitive biologics market on Monday, announcing the European debut of Gobivaz, the first biosimilar to the blockbuster inflammatory drug Simponi to reach the market anywhere in the world.